Cryoprotectant
Release time:
2017-03-13
Cryoprotectants are the basis for research on cryopreservation of various human cells, tissues, and organs. Since the discovery of the cryoprotective effect of glycerol in the 1960s, more than 50 drugs or reagents have been used for cryoprotection. In recent years, with the development of vitrification technology, in-depth research on cryoprotectants has attracted the attention of many researchers.
The cryopreservation of biological sample tissues usually includes two types: subnormal temperature preservation of 2 to 10°C and deep cryopreservation of -80 to -196°C. Subnormal temperature storage of 2 to 10°C is usually suitable for tissues and organs that can be transplanted or transported in a short time. Commonly used protective solutions include UW solution developed by the University of Wisconsin and has been clinically used for nearly 20 years, and was studied by Georges Lopez of France. The developed IGL solution, a low-potassium, low-sodium, non-body fluid HTK preservation solution, combines the advantages of UW solution and HTK solution, and is used in Celsior solution (CS solution) for cardiac preservation. Several cryopreservation solutions with relatively good effects, such as SMO solution (Shanghai Multi-Organ Preservation Solution), have also been developed in China. In addition, there are EC fluids that are widely used in Europe for standard preservation of clinical kidney transplants, and HC-A fluids that are mainly used for lavage and cryopreservation of organ transplants in China.
With the advancement of science and technology and the increasing demand for long-term preservation of samples, cryopreservation has become the only choice for cell, tissue and organ preservation research. Currently, liquid nitrogen cryopreservation has widely become the best way to preserve various cells and tissues. Way.
Cryoprotectants can be divided into two categories based on their role in cryogenic preservation: permeable and non-permeable protectants. Penetration protective agents are mainly polyols, including ethylene glycol (EG), dimethyl sulfoxide (DMSO), propylene glycol, glycerol, formamide and acetamide, etc. The role of osmotic protectants is to reduce or avoid the formation of intracellular ice crystals by lowering the freezing point and replacing the water around intracellular proteins, DNA and other components. Non-permeable protective agents mainly include low molecular weight monosaccharides (fructose, glucose, maltose, etc.), disaccharides (sucrose, trehalose, etc.), polysaccharides (raffinose, etc.) and polymer compounds with a molecular weight greater than 1000 Da ( Polysucrose, dextran, polyvinylpyrrolidone, polyethylene glycol, polyvinyl alcohol and hydroxyethyl starch, etc.). The non-permeable protective agent is beneficial to improving the vitrification properties of the protective solution and improving the cryoprotective effect. At the same time, it promotes cell dehydration through osmosis, stabilizes the cell membrane, and reduces the amount of cryoprotectant required to achieve vitrification itself, thus reducing the vitrification solution. toxicity.
Ice blockers, antifreeze proteins, magnetic nanoparticles, and even some Chinese herbal ingredients (such as ginsenosides) and other new substances that are different from the above two categories have also been documented to have good cryoprotective effects. Conduct systematic analysis of the above various substances, screen appropriate combinations of cryoprotective substances according to the properties and requirements of different cryoprotection biological samples, and use advanced instruments and technical means to conduct parameter determination, cooling and recovery procedures screening to protect biological samples from ice crystals Damage, thereby providing good biological samples for clinical and basic scientific research, has become a new research direction.
In addition, on the basis of the research and development of existing protective agents, we should also actively pay attention to some other substances with potential application value, such as antioxidants (propyl citrate, vitamin E, vitamin C, amino acids, lecithin, protein hydrolysates, Sodium thiosulfate, sodium ascorbate), etc., finding alternative ingredients for commonly used toxic protective substances such as DMSO, and developing low-toxic or even non-toxic cryoprotectants is also an important research direction for us.
On the basis of the existing deep cryopreservation of various cells, more protective substances are selected and optimized, combined with new substances such as antifreeze proteins and nanomagnetic particles, and appropriate cooling and rewarming procedures are selected to achieve the preservation of samples such as clinical tissues and organs. High quality preservation.
Previous article
Next article
Previous article
Next article
Latest developments
Over the two days, the symposium was not only a collision of ideas but also seeds sown to advance social progress in life culture. The Shandong Yinfeng Life Science Public Welfare Foundation will continue to use technology as wings and culture as roots, collaborating with all sectors of society to enhance the quality of life for the Chinese people and build a human-centered life care system.
According to recent announcements by the Jinan Municipal Bureau of Science and Technology, 11 outstanding achievements from Jinan have been included in the 2025 "Shandong Outstanding Achievements Report" project. Among them is the globally first-of-its-kind ovarian tissue dual-activation technology developed by Shandong Silver Med Life Science Research Institute (Jinan).
Recently, Frigid Zone Medicine, an authoritative international journal in the field of cryomedicine, published an important review titled "Advances in the Detection Methods for Assessing the Viability of Cryopreserved Samples". Written by the team of Yinfeng Cryomedical Research Center, the article systematically reviews and analyzes various detection techniques currently used to evaluate the viability of cryopreserved cells, tissues, and organs. It also proposes key directions from the perspectives of methodological integration and future instrument development, offering crucial theoretical support and practical guidance for the long - term cryopreservation of complex tissues and organs.
Recently, the "Novel Technology for Ultra-Low Temperature Cryopreservation, Activation, and Transplantation of Human Ovarian Tissue," developed through a collaborative effort between Shandong Yinfeng Life Science Research Institute and Beijing University of Chinese Medicine Shenzhen Hospital, has been awarded the 2025 Shandong Refrigeration and Air Conditioning Science and Technology Award. This groundbreaking technology pioneers a new pathway for female fertility preservation, marking a significant leap in China’s interdisciplinary advancements in reproductive medicine and cryobiology.
On May 19, a delegation from the Chinese Training Workshop for Government Officials of Developing Countries visited the exhibition hall of Yinfeng Biological Group's Cryomedicine Research Center. Government officials from multiple countries gained in-depth insights into Yinfeng’s innovative achievements in cryobiomedicine, cell storage, genetic technology, and other fields. They engaged in discussions with the delegation on technology transfer and international cooperation, contributing to the building of a global community with a shared future for humanity.
Yinfeng Life Continuation Plan
Address: Yinfeng Biotechnology Park, 1758 Gangyuan 6th Road, High-tech Zone, Jinan City, Shandong Province
Zip Code: 250102
Telephone: 0086-0531-88897351
Mobile: 0086-19953155507
Mobile website
Official WeChat Public Number
Links:Red Cross Society of China丨Shandong Red Cross Society丨Shandong Provincial Health Commission | Yinfeng Group| Yinfeng Biological Group
All rights reserved©Yinfeng Life Continuation Powered by www.300.cn SEO
